Top researchers at Memorial Sloan Kettering Cancer Center have filed at least seven corrections with medical journals recently, divulging financial relationships with health care companies that they did not previously disclose

Quick Read

Drug companies make big contributions to analysis in the trials they fund but can fail to report their contributions

Quick Read

Academic institutions are breaching rules by failing to report the results of clinical trials, new research shows. A study, published in journal BMJ, found “poor” compliance with EU regulations which require outcomes to be posted to a central register within 12 months

Quick Read

One of the world’s top breast cancer doctors failed to disclose millions of dollars in payments from drug and health care companies in recent years, omitting his financial ties from dozens of research articles in prestigious publications like The New England Journal of Medicine and The Lancet

Quick Read

Frustrated with the slow transition towards open access (OA) in scientific publishing, 11 national funding organizations in Europe turned up the pressure today. As of 2020, the group, which jointly spends around €7.6 billion on research annually, will require every paper it funds to be freely available from the moment of publication

Quick Read

Interventions such as speeding enforcement and formal swimming lessons for young children could potentially save more than 250,000 lives a year if they were implemented across populations living in extreme poverty in low- and middle-income countries, according to a new study from researchers at the Johns Hopkins Bloomberg School of Public Health, including our Adnan Hyder

Quick Read

A paper on overdose-reversal drugs reached a conclusion no one liked. The pushback raised questions about sexism and scientific methods

Quick Read

Critics wonder why

Quick Read